Onderneming ASLAN Pharmaceuticals Limited Taipei Exchange
Aandelen
6497
KYG054241099
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Novel Drugs
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| - | - | 12 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Carl Firth
FOU | Founder | 51 | 01-01-10 |
Kiran Asarpota
DFI | Director of Finance/CFO | 45 | 01-11-10 |
Chief Tech/Sci/R&D Officer | - | 15-03-22 | |
Stephen Doyle
PRN | Corporate Officer/Principal | 50 | 01-02-18 |
Ben Goodger
LAW | General Counsel | 61 | 01-11-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hoffman
BRD | Director/Board Member | 58 | 30-10-18 |
Andrew Howden
CHM | Chairman | 64 | 01-04-16 |
Carl Firth
FOU | Founder | 51 | 01-01-10 |
Kathleen Metters
BRD | Director/Board Member | 66 | 18-03-21 |
Neil Graham
BRD | Director/Board Member | 65 | 18-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 337 297 360 | 333 924 386 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
Aslan Pharmaceuticals Ltd.
3 Temasek Avenue 18 Level Centennial Tower
039190, Singapore
+
http://www.aslanpharma.com![Adres ASLAN Pharmaceuticals Limited(6497)](https://cdn.zonebourse.com/static/address/42075699.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,20% | 121 mld. | |
+19,67% | 113 mld. | |
+18,95% | 26,02 mld. | |
-23,86% | 19,39 mld. | |
-19,03% | 15,91 mld. | |
-20,90% | 15,09 mld. | |
-46,14% | 15,06 mld. | |
+63,85% | 14,93 mld. | |
+4,49% | 13,85 mld. |